|
Cardiology / Original Article
The efficacy and safety of on-label reduced-dose apixaban in patients with atrial fibrillation in real-world practice
Min-Su Jung, Jongmin Hwang, Seongwook Han, Hyoung-Seob Park, Tae-Wan Chung, Eue-Keun Choi, Il-Young Oh, Hyung Wook Park, Sung Ho Lee, Jong-Sung Park, Yae Min Park, Gyo-Seung Hwang, Dong-Hyeok Kim, Jin-Kyu Park, Jong-Il Choi; on behalf of the INSPIRE study investigators
Korean J Intern Med. 2026;41(6):1077-1086. Published online November 1, 2026
Background/Aims: In pivotal randomized trials, only a small proportion of patients received the reduced apixaban dose, limiting the generalizability of those findings. We evaluated the efficacy and safety of on-label reduced-dose apixaban in Korean patients with atrial fibrillation (AF).
Methods: Pat..
|